The catheterized urinary tract provides ideal conditions for the development of biofilm populations. Catheter-associated urinary tract infections (CAUTIs) are recalcitrant to existing antimicrobial treatments; therefore, established biofilms are not eradicated completely after treatment and surviving biofilm cells will carry on the infection. Cis-2-decenoic acid (CDA), an unsaturated fatty acid, is capable of inhibiting biofilm formation by Pseudomonas aeruginosa and of inducing the dispersion of established biofilms by multiple types of micro-organisms. Here, the ability of CDA to induce dispersal in pre-established single-and dual-species biofilms formed by Escherichia coli and Klebsiella pneumoniae was measured by using both semi-batch and continuous cultures bioassays. Removal of the biofilms by combined CDA and antibiotics (ciprofloxacin or ampicillin) was evaluated using microtitre plate assays (crystal violet staining). The c.f.u. counts were determined to assess the potential of combined CDA treatments to kill and eradicate preestablished biofilms formed on catheters. The effects of combined CDA treatments on biofilm surface area and bacteria viability were evaluated using fluorescence microscopy, digital image analysis and live/dead staining. To investigate the ability of CDA to prevent biofilm formation, single and mixed cultures were grown in the presence and absence of CDA. Treatment of preestablished biofilms with only 310 nM CDA resulted in at least threefold increase in the number of planktonic cells in all cultures tested. Whilst none of the antibiotics alone exerted a significant effect on c.f.u. counts and percentage of surface area covered by the biofilms, combined CDA treatments led to at least a 78 % reduction in biofilm biomass in all cases. Moreover, most of the biofilm cells remaining on the surface were killed by antibiotics. The addition of 310 nM CDA significantly prevented biofilm formation by the tested micro-organisms, even within mixed cultures, indicating the ability of CDA to inhibit biofilm formation by other types of bacteria in addition to Pseudomonas aeruginosa. These findings suggested that the biofilm-preventive characteristics of CDA make it a noble candidate for inhibition of biofilm-associated infections such as CAUTIs, which paves the way toward developing new strategies to control biofilms in clinical as well as industrial settings.
INTRODUCTION
The biofilm mode of growth is a basic survival strategy deployed by bacteria in a wide range of environmental, industrial and clinical settings (Stoodley et al., 2002) . The catheterized urinary tract provides ideal conditions for the development of enormous biofilm populations. Consequently, catheter-associated urinary tract infections (CAUTIs) are amongst the most common infectious diseases of humans, and significantly burden the healthcare system by increasing both morbidity and treatment costs (Ulett et al., 2007) . The initial infections are usually by single bacterial species, such as Escherichia coli, Staphylococcus epidermidis and Enterococcus faecalis (Stickler, 2008) . However, over time, a variety of organisms, including Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis and Morganella morganii, colonize the bladder urine and form poly-microbial communities that are embedded in protective self-produced extracellular polymeric substances (EPSs) (Stickler, 2008) . In order to inactivate these encased cells, antimicrobial molecules must diffuse through the biofilm EPSs and gain access to the microbial cells in sufficient concentrations (Walters et al., 2003) . However, EPSs present a diffusional barrier for these molecules either by influencing the rate of transport of the molecule to the biofilm interior (e.g. ciprofloxacin and ampicillin) (Anderl et al., 2000) or by reaction of the antimicrobial material with the matrix material (Campanac et al., 2002) . Thus, micro-organisms that are sensitive to antibiotics in their planktonic phenotype become resistant in their biofilm mode of growth (Stickler, 2008) . This characteristic makes CAUTIs, like other biofilm-associated infections, recalcitrant to treatment by using existing antimicrobial treatments, and it is a common and frustrating experience that after treatment, established biofilms are not completely eradicated and surviving biofilm cells carry on the infection (Fux et al., 2005) . To address the need for novel and improved measures against biofilms, especially preestablished biofilms, a clear strategy is to study the biofilm life cycle and identify key trigger points that regulate biofilm development. To control biofilm, the last stage of biofilm development presents several advantages, when a coordinated dispersal of biofilm cells is possible. Induction of biofilm dispersal can potentially use the micro-organisms' own energy to remove EPSs and disrupt pre-established biofilms, which results in cells reverting to a planktonic phenotype and restores their susceptibility to antibiotics. It has been reported recently that Pseudomonas aeruginosa produces a diffusible signal factor family signal, cis-2-decenoic acid (CDA), which is capable of inhibiting biofilm formation by Pseudomonas aeruginosa and of inducing the dispersion of established biofilms by multiple types of micro-organisms (bacteria as well as yeast) (Davies & Marques, 2009 ). In fact, CDA is involved in inter-species and inter-kingdom signalling where it can modulate the behaviour of other micro-organisms that do not produce the signal (Davies & Marques, 2009) . Its broad spectrum of activity in addition to the fact that it has no cytotoxic effects on human cells at the nanomolar range (Jennings et al., 2012) makes CDA a promising candidate for the control of biofilms. However, there is limited information on the potential of CDA to boost the actions of antimicrobial agents.
Therefore, in the current work the ability of CDA to induce dispersal in established single-and dual-species biofilms formed by E. coli and K. pneumoniae, and to eradicate their biofilms when combined with antibiotics, was studied. In addition, the ability of CDA to prevent biofilm formation by these pathogens and to increase the inhibitory effects of antibiotics on the growth of bacterial planktonic cells was investigated.
METHODS
Bacterial strains, media and growth conditions. The microorganisms used in the present study included E. coli (ATCC 25922) and K. pneumoniae (ATCC 700603). All cultivations were performed in artificial urine adopted by Griffith et al. (1976) . The pH of the medium was adjusted to 6.1 and then the medium was sterilized by membrane filtration. Tryptone soya broth (Merck) was prepared separately, autoclaved and added to the sterile basal medium to a final concentration of 1.0 g l
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. Medium was supplemented (as required) with antibiotic (chloramphenicol at a final concentration of 20 mg ml 21 ).
Chemicals and antimicrobial compounds. Three different concentrations of CDA (U-Chemo; 100, 310 or 620 nM) were used. These concentrations were observed previously to have the most effect on inducing the dispersion of pre-established biofilms and on inhibiting biofilm development (Davies & Marques, 2009 ) with no cytotoxic effects on human cells (Jennings et al., 2012) . Ethanol (10 %) (Merck) was used as a carrier for CDA. This study also examined the effects of two antibiotics, ciprofloxacin (Sigma) and ampicillin (Sigma), which are used widely in treatment of urinary tract infections. Ciprofloxacin was used at a final concentration of 1 mg ml 21 and ampicillin was used at a final concentration of 256 mg ml 21 . The concentration of the selected antibiotics was established in our laboratory to be effective against planktonic cells, but have no inhibitory effect on the biofilm cells of the test micro-organisms.
Single-and dual-species biofilm dispersal bioassays in Petri dishes. Single-species biofilms of E. coli and K. pneumoniae as well as their dual-species biofilms were cultivated on the inside surface of sterile Petri dishes (Barraud et al., 2006) . Plates were incubated for 5 days at 37 uC with shaking at 30 r.p.m., in triplicate. Medium in the plates was replaced every 24 h to reduce the accumulation of native dispersion-inducing factors and to allow mature biofilms to form. After the final exchange of medium, the cells were allowed to grow for 1 h and then dispersion induction was tested by replacing the growth medium with fresh medium containing one of the indicated concentrations of CDA (100, 310 or 620 nM) or just the carrier as a control and the cells were incubated for a further 1 h. Medium containing dispersed cells was then homogenized for 30 s at 5000 r.p.m. and cell density was determined based on the OD 600 .
Dispersion bioassays in biofilm tube reactors. Single-and dualspecies biofilms were also grown on the interior surfaces of tubing of a once-through continuous-flow reactor system at 37 uC. The silicone tubes were inoculated by syringe injection through a septum 1 cm upstream from each reactor tube with 3 ml of overnight cultures of each micro-organism to cultivate single-species biofilms. To grow dualspecies biofilms, 1.5 ml overnight cultures of E. coli and K. pneumoniae were mixed well and then used as inoculum. Cells were allowed to attach (static incubation) to the tubing for 1 h, after which the flow was started at an elution rate of 280 ml min
. After 5 days of biofilm culture, the influent medium was switched from fresh medium in the test lines to one of the three indicated concentrations of CDA. Control lines were switched to new lines containing just the carrier. Samples were collected in test tubes on ice and were subsequently homogenized, and cell density was determined as described above.
Combined CDA and antibiotic biofilm microtitre plate assays.
To assess the effect of antibiotics alone or in combination with CDA, biofilms were grown on the inside surface of sterile polystyrene 96-well plates. To cultivate biofilms, plates were inoculated with either 150 ml per well of overnight culture of each test micro-organism (to grow single-species biofilms) or mixtures of two bacteria overnight cultures (to cultivate dual-species biofilms) and then were incubated at 37 uC with shaking at 120 r.p.m. Medium within each well was replaced every 24 h for 5 days. The biofilms were then treated for 1 h with the indicated concentrations of antibiotics alone or combined with 310 nM CDA and biofilms were monitored by crystal violet staining as described by Musk & Hergenrother (2008) . All experiments were repeated at least four times.
Biofilm formation on catheters. Biofilm formation was also assayed under hydrodynamic conditions in silicone catheters. Pieces of catheter (100 % silicon) with a length of 3.0 cm were cut, sterilized in 0.5 % sodium hypochlorite for 1 h and then washed extensively with sterile water. Each piece of catheter was put into a glass tube with 5.0 ml growth medium. The tubes were then inoculated with 50 ml of a culture of each test micro-organism freshly grown overnight (to cultivate single-species biofilms) or their mixtures (to grow dualspecies biofilms). The tubes were left at 37 uC in a water bath with shaking at 110 r.p.m. for 5 days. Medium in each tube was replaced every 24 h for 5 days. The biofilms were then treated for 1 h with the indicated concentrations of antibiotics alone or combined with 310 nM CDA. The amount of adhered bacteria on the catheters was examined by viable counts. The catheter pieces were first washed in 50 ml PBS three times and excess liquid was removed by capillarity on adsorbent paper to reduce the influence of non-attached or loosely attached bacteria. The catheter pieces were then placed into plastic tubes containing 5.0 ml PBS. Adhered bacteria were detached by sonication for 4 min at 42 Hz at room temperature, followed by vortexing at maximum velocity for 15 s, and then serial dilution and plating onto LB agar plates. The sonication procedure did not adversely affect bacterial viability (this was confirmed by plating samples of bacterial liquid cultures before and after sonication).
Flow cell (continuous culture) biofilm experiments, antibiotics sensitivity assays and surface area coverage. To observe the effect of combined CDA and antibiotic treatments on biofilm surface area and bacteria viability, single-and dual-species biofilms of GFPexpressing E. coli and K. pneumoniae carrying plasmid pAmr93 (generously provided by E. Peter Greenberg, Department of Microbiology, University of Washington, School of Medicine, Seattle WA, USA) were also grown in synthetic urine, supplemented with chloramphenicol at 37 uC in continuous culture flow cells (channel dimensions, 164640 mm). After 48 h of biofilm culture, the influent medium was switched from fresh medium in the test lines to the antibiotics alone or in combination with 310 nM CDA. After 1 h treatment, biofilms were stained with 30 mM propidium iodide, which labels dead cells red. Using epifluorescence microscopy (CETI), 15 selected fields of view per flow cell were imaged in the xy plane, at regular intervals and across the entire channels. Image analysis (ImageJ software; http://imagej.nih.gov/ij/) was performed, and results were presented as the percentage of total biofilm surface reduction in cultures subjected to combined CDA and antibiotic treatments relative to the total biofilm surface in control cultures that were not exposed to CDA. Statistical comparison of the percentage of surface covered by biofilms in the different treatments was performed using ANOVA. Three replicates per experiment were used and at least two independent repetition experiments were performed.
Inhibition of biofilm formation on catheters by CDA. Biofilm formation was assayed in silicone catheters. Each piece of catheter was put into a glass tube with 5.0 ml growth medium (as described above) with or without 310 nM CDA. The tubes were then inoculated with 50 ml overnight culture of each test micro-organism (to cultivate singlespecies biofilms) or their mixtures (to grow dual-species biofilms). The tubes were then left at 37 uC in a water bath with shaking at 110 r.p.m. for 24 h before analysis. After plating onto LB agar, c.f.u. were counted.
Combined CDA and antibiotic treatment of planktonic cells.
We have also evaluated the probable inhibitory effects of antibiotics alone or in combination with three different concentrations of CDA (100, 310 or 620 nM) on the growth of planktonic cells of the test micro-organisms. The MICs were determined in triplicate in Mueller-Hinton broth by using a microdilution assay with bacteria at a density of 10 5 c.f.u. ml
. Plates were incubated for 24 h at 37 uC. The lowest concentration of antibiotics where there was no growth after 24 h was taken as the MIC (CLSI, 2006) .
RESULTS

Very low concentrations of CDA induce biofilm dispersal
We investigated the effect of exposure to nanomolar concentrations of CDA on pre-established single-and dualspecies biofilms in Petri dish cultures. CDA treatments resulted in a significant increase in the populations of planktonic cells released into the bulk liquid compared with untreated control samples. The greatest effect was observed repeatedly with 310 nM CDA with at least a threefold increase in the number of planktonic cells. At this concentration, the largest increase in the planktonic population was observed in the case of single-species biofilms of K. pneumoniae and also dual-species biofilms (OD 600 0.92±0.01, P¡0.05 and 1.10±0.01, P¡0.05, respectively) versus untreated controls (OD 600 50.62±0.01, P¡0.05 and 0.78±0.02, P¡0.05, respectively). The results from these experiments are summarized in Table 1 . We also examined the effect of exposure to very low concentrations of CDA on preestablished biofilms grown in continuous cultures on the inner surface of silicone tubing. We again observed an increase in the population of planktonic cells after treatment with CDA, indicating the release of biofilm bacteria into the effluent of cultures treated with CDA. As for semi-batch biofilm cultures, a threefold increase in the number of planktonic cells in the effluent runoffs was observed in cultures treated with 310 nM CDA (Table 2) , which was the largest increase in all cases. At this concentration, CDA caused a significant increase in the population of planktonic cells especially in dual-species biofilms (OD 600 0.51±0.03, P¡0.05) compared with the results for untreated controls (OD 600 0.18±0.01, P¡0.05). Therefore, 310 nM CDA was used for further studies.
The results from these two different dispersal bioassays demonstrated the ability of CDA to stimulate the release of cells from established biofilms, formed by catheterassociated bacteria, even within mixed cultures.
Combined CDA and antibiotic treatment killed and removed pre-established biofilms formed on different surfaces
We tested the effectiveness of combined CDA treatments on the removal of pre-established single-and dual-species biofilms formed on the inside surface of polystyrene 96-well plates. After 120 h growth, biofilms were treated with two antibiotics (ampicillin or ciprofloxacin) at the indicated concentrations, alone or in combination with 310 nM CDA. The remaining biofilms were then stained with 0.1 % crystal violet. We observed that combined treatments with both CDA and antibiotics had a significant effect on removing pre-established biofilms (e.g. in the absence of CDA, ampicillin caused only 21 % reduction in dual-species biofilms, whereas addition of 310 nM CDA resulted in 78 % biofilm removal) (Fig. 1a) . However, the largest biofilm removal was observed when both types of biofilms were treated with a combination of CDA and ciprofloxacin, which resulted in 90 % reduction in biofilm biomass in single-species biofilms and~80 % biofilm removal in dual-species biofilms (Fig. 1a) .
We also examined the effect of combined CDA and antibiotic treatment on the killing and eradication of preestablished biofilms grown on urinary catheters. When 120 h biofilms were treated in the absence of CDA, both antibiotics caused a roughly twofold decrease in c.f.u. counts compared with untreated controls, whilst combined exposure of cultures to either 310 nM CDA and only 256 mg ampicillin ml 21 or 310 nM CDA and 1 mg ciprofloxacin ml 21 resulted in at least a fourfold decrease in c.f.u. counts (Fig. 1b) . This demonstrated that CDA removed biofilms not only from the polystyrene surfaces, as shown in microtitre plates, but also from silicone surfaces of urinary catheters.
Combined CDA and antibiotic treatment significantly reduced biofilm surface coverage
To further examine the effect of CDA on biofilm eradication, we also tested combined CDA and antibiotic treatment against pre-established biofilms cultivated in continuous culture flow cells. When 48 h biofilms were treated in the absence of CDA, none of the antibiotics exerted a significant effect on the percentage of surface area covered by the biofilms (Fig. 2) . In contrast, after combined treatment, the biofilm cells remaining on the surface were easily removed and killed by antibiotics when examined by using live/dead staining (Fig. 2) . As for microtitre assays, the largest reduction in biofilm biomass was observed when pre-established single-and dual-species biofilms were treated with a combination of CDA and ciprofloxacin, giving~90 and 80 % biofilm removal, respectively (Fig. 2a) .
Therefore, combined treatments with both CDA and antibiotics caused almost complete removal of preestablished single-and dual-species biofilms formed by catheter-associated micro-organisms.
CDA prevented biofilm formation on urinary catheters
Test micro-organisms were also used to investigate the inhibitory role of additional CDA in biofilm formation by both single-and mixed-cultures on silicone catheters. Determinations of c.f.u. (mm catheter) -1 revealed a twofold reduction in biofilms by only 310 nM CDA (Fig.  3) , indicating the ability of CDA to inhibit biofilm formation by other types of bacteria in addition to Pseudomonas aeruginosa.
To further investigate the effect of CDA on the sensitivity of test micro-organisms towards antibiotics, we also evaluated very low concentrations of CDA for inhibitory effects on the A. Rahmani-Badi and others growth of planktonic cells. Compared with antibiotics alone, the combination of nanomolar concentrations of CDA with antibiotics had no additional inhibitory effects on the growth of planktonic cells (Table 3) .
DISCUSSION
Microbial biofilms are an increasing concern in the medical field where the use of artificial medical devices for therapeutic and restorative purposes is on the rise. CAUTIs are notable examples of this, and illustrate the significant economic and medical problems associated with the use of such devices (Stamm, 1991; Tambyah et al., 2002) .
In the long quest aiming to prevent or reduce the accumulation of microbial biofilms, many different strategies have been proposed with different degrees of success (Yang et al., 2012) . In various industrial settings, a range of biocides and toxic metals (e.g. tin and copper) have been used for antifouling coatings and sanitizing purposes (Cloete et al., 1998; Chambers et al., 2006) . These substances are, however, not appropriate for use in medical implants and therefore other strategies have been sought. For example, in urology, a range of urinary catheters has been developed which incorporate and/or release antimicrobial compounds, e.g. metals (such as silver salts) and antibiotics (Darouiche et al., 1999; Johnson et al., 2006) . Nevertheless, the general risk of antibiotic resistance development associated with these compounds has resulted Fig. 1 . Effect of CDA in combination with antibiotics on pre-established single-and dual-species biofilm removal. (a) The amount of biofilm remaining after treatment with the tested concentrations of antibiotics [ampicillin (Amp) and ciprofloxacin (Cip)] alone (-CDA) or in combination with 310 nM CDA (+CDA) for 1 h was determined by the measurement of A 590 of crystal violet by staining the 120 h biofilms in a microtitre plate assay. All readings are corrected to reflect 0 and 100 % controls (blank well, 0 %; biofilms without any treatments, 100 %). Bar, SD (n54). (b) After treatment of the biofilms with antibiotics alone or combined with 310 nM CDA, c.f.u. plate counts were determined to assess the viability of the bacteria (n59).
in limited use of such strategies (Ramos et al., 2011) . Therefore, additional strategies are being developed in order to reduce catheter-associated biofilms. In a previous study, Cobrado et al. (2012) suggested that cerium nitrate, low-molecular-mass chitosan and hamamelitannin are biocompatible compounds that could be used to coat medical devices. However, their in vivo studies revealed that amongst these compounds, only hamamelitannin could inhibit biofilm formation by all the bacteria tested. According to Cobrado et al. (2013) , a more durable coating strategy and further in vivo testing for these compounds are needed in order to develop a cost-effective and biocompatible indwelling catheter that could reduce medical deviceassociated biofilms more effectively than the present available options.
The main feature of biofilms is the production of EPSs to build a matrix for embedding the cells, and protecting them from shearing forces and undesirable conditions, including the presence of most antimicrobial agents (Flemming & Wingender, 2010) . In a previous study, Davies & Marques (2009) reported that CDA, a signalling molecule synthesized by Pseudomonas aeruginosa, induces dispersion of pre-established biofilms in this bacterium, as well as many other strains of micro-organisms. Induction of biofilm dispersal can potentially use the microorganisms' own energy to remove EPSs and disrupt preestablished biofilms, revert cells to a planktonic phenotype, and restore their susceptibility to antimicrobial agents. Therefore, in this study, we first examined the impacts of nanomolar concentrations of CDA (as an inducer of biofilm dispersal) on dispersion of single-and mixedspecies biofilms formed by the top two species in CAUTIs, E. coli and K. pneumoniae, which are also excellent biofilm formers (Dalgaard, 1995; Hancock et al., 2010) . Our data showed that treatment of pre-established biofilms with only 310 nM CDA resulted in at least a threefold increase in the number of planktonic cells in all the cultures tested. Then, we successfully removed both types of biofilm culture by using a combination of CDA and common antibiotics at concentrations that had not been significantly effective against biofilms in previous studies (Barraud et al., 2006) . The results presented here demonstrated that following exposure to low concentrations of CDA, cells remaining on the surface were easily killed by antibiotics even within mixed cultures. We confirmed that the combination of 310 nM CDA with ciprofloxacin and ampicillin, which are used widely in the treatment of CAUTIs, resulted in up to 90 % reduction in biofilm biomass in all cases. Moreover, live/dead staining experiments showed that most of the biofilm cells remaining on the surface were killed by antibiotics. We also showed that, in addition to dispersal of pre-established biofilms, CDA inhibited biofilm formation by bacterial species other than Pseudomonas aeruginosa. This anti-biofilm activity could be useful in prophylactic measures for preventing biofilmassociated infections such as CAUTIs. CDA-based strategies to induce biofilm dispersal or to prevent biofilm formation contain very low concentrations of CDA, only in the nanomolar range, which should be safe to humans and to the environment. Moreover, in a previous study, Jennings et al. (2012) have shown that CDA has no cytotoxic or stimulatory effect on human cells even at high concentrations (up to 250 mg ml
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). Some free fatty acids have been reported to have antimicrobial properties (Desbois et al., 2008; Desbois & Smith, 2010) and play an important role in maintaining the microbial flora of the skin (Kenny et al., 2009; Takigawa et al., 2005) . However, we demonstrated that CDA did not inhibit bacterial growth at the nanomolar range that induces biofilm dispersal. These results were highly consistent with results obtained from Jennings et al. (2012) showing that CDA inhibited bacterial growth only at micro-to millimolar concentrations. This lack of growth inhibition at lower concentrations was not surprising as bacteria produce this fatty acid and use it as a signalling molecule (Davies & Marques, 2009) . CDA mediates the transition from a biofilm to a planktonic phenotype via a signalling mechanism (because it acts at nanomolar concentrations, consistent with all known cell-cell signalling molecules) rather than a toxic effect. Therefore, CDA-based biofilm control strategies would not be expected to select for resistant strains, as seen with antibiotics. The application of a dispersion inducer prior to, or in combination with, treatment by antimicrobial agents provides a promising mechanism for enhancing the activity of these treatments through the disruption of existing biofilms. pneumoniae on urinary catheters. Biofilm formation by test bacteria in synthetic urine in the presence and absence of 310 nM CDA was examined on urinary catheters (100 % silicone) by viable counts. Catheters were incubated for 24 h, washed and sonicated, and serial dilutions were plated for determination of c.f.u. Results displayed are mean±SD of three replicates. Bacteria formed significantly less biofilm on catheters in medium with CDA ('310 nM CDA') than in medium without additional CDA ('No CDA') (P,0.01 by t-test). 
